VATHLT8320 - The zero rate for free-of-charge medicines: Clinical trials: Medicines supplied for the continuation of treatment after a clinical trial
Where a patient has participated in a clinical trial that has been authorised by the MHRA, and the same product is supplied free of charge for this patient’s ongoing treatment after the trial has ended, this supply may be zero-rated under item 1ZC(a). If the treatment is provided by the NHS or the treatment is commissioned or funded by the NHS, this may be zero-rated under either item 1ZB or 1ZC(b). Where the treatment is provided outside of the NHS, this will qualify for zero-rating under item 1ZC(a).
For the zero rate to apply, there needs to be no charge to the patient or to any other person for the medicinal product itself.
As with supplies for use in the NHS, such supplies must be ‘authorised supplies’ as defined in VATHLT8230.
The zero rate applies whether or not there was a pre-existing commitment to ongoing access to the medicinal product after the clinical trial had ended.
The medicinal product needs to be the same product as the patient received in the clinical trial in which the patient participated. During the clinical trial, this will be classed as an investigational medicinal product or non-investigational medicinal product under The Medicines for Human Use (Clinical Trials) Regulations 2004. Outside of a clinical trial, it will be classed as a medicinal product under The Human Medicines Regulations 2012 Regulation 2(1).